Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-04-24 @ 12:54 AM
Study NCT ID:
NCT02628951
Status:
COMPLETED
Last Update Posted:
2020-11-19
First Post:
2015-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-06
First Submit QC Date:
None
Study First Post Date:
2015-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-17
Last Update Post Date:
2020-11-19
Last Update Post Date Type:
ACTUAL